Inducible nitric oxide synthase-deficient mice develop enhanced type 1 cytokine-associated cellular and humoral immune responses after vaccination with attenuated Schistosoma mansoni cercariae but display partially reduced resistance

Infection and Immunity

Volumn 66, Issue 8, 1998, Pages 3510-3518

  James, Stephanie L ^a   Cheever, Allen W ^b   Caspar, Patricia ^a   Wynn, Thomas A ^a,c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b BIOMEDICAL RESEARCH INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CERCARIA; CONTROLLED STUDY; IMMUNOMODULATION; IMMUNOREACTIVITY; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; VACCINATION;

EID: 0031848298     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.8.3510-3518.1998     Document Type: Article

References (47)

1. Ahmed, S. F., I. P. Oswald, P. Caspar, S. Hieny, L. Keefer, A. Sher, and S. L. James. 1997. Developmental differences determine larval susceptibility to nitric oxide-mediated killing in a murine model of vaccination against Schistosoma mansoni. Infect. Immun. 65:219-226.
2. Albina, J. E., J. A. Abate, and W. L. Henry, Jr. 1991. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway. J. Immunol. 147:144-148.
3. Albina, J. E., S. Cui, R. B. Mateo, and J. S. Reichner. 1993. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150: 5080-5085.
4. Bauer, H., T. Jung, D. Tsikas, D. O. Stichtenoth, J. C. Frolich, and C. Neumann. 1997. Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells. Immunology 90: 205-211.
5. Bergquist, N. R. 1995. Schistosomiasis vaccine development: approaches and prospects. Mem. Inst. Oswaldo Cruz Rio J. 90:221-227.
6. Chang, R. H., M. H. Feng, W. H. Liu, and M. Z. Lai. 1997. Nitric oxide increased interleukin-4 expression in T lymphocytes. Immunology 90:364-369.
7. Coulson, P. S. 1997. The radiation-attenuated vaccine against schistosomes in animal models: paradigm for a human vaccine? Adv. Parasitol. 39:271-336.
8. Coulson, P. S., L. E. Smythies, C. Betts, N. A. Mabbott, J. M. Sternberg, X.-G. Wei, F. Y. Liew, and R. A. Wilson. 1998. Nitric oxide produced in the lungs of mice immunized with the radiation-attenuated schistosome vaccine is not the major agent causing challenge parasite elimination. Immunology 93:55-63.
9. Dean, D. A., and B. L. Mangold. 1992. Evidence that both normal and immune elimination of Schistosoma mansoni take place at the lung stage of migration prior to parasite death. Am. J. Trop. Med. Hyg. 47:238-248.
10. DeCaterina, R., P. Libby, H. B. Peng, V. J. Thannickal, T. B. Rajavashisth, M. A. Gimbrone, Jr., W. S. Shin, and J. K. Liao. 1995. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96:60-68.
11. Falzarano, G., W. Krenger, K. M. Snyder, J. Delmonte, Jr., M. Karandikar, and J. L. Ferrara. 1996. Suppression of B-cell proliferation to lipopolysaccharide is mediated through induction of the nitric oxide pathway by tumor necrosis factor-alpha in mice with acute graft-versus-host disease. Blood 87:2853-2860.
12. Florquin, S., Z. Amraoui, C. Dubois, J. Decuyper, and M. Goldman. 1994. The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice. J. Exp. Med. 180:1153-1158.
13. Freeman, G. L., Jr., A. Tominaga, K. Takatsu, W. E. Secor, and D. G. Colley. 1995. Elevated innate peripheral blood eosinophilia fails to augment irradiated cercarial vaccine-induced resistance to Schistosoma mansoni in IL-5 transgenic mice. J. Parasitol. 81:1010-1041.
14. James, S. L., E. Skamene, and M. S. Meltzer. 1983. Macrophages as effector cells of protective immunity in murine schistosomiasis. V. Variation in macrophage schistosomulacidal and tumoricidal activities among mouse strains and correlation with resistance to reinfection. J. Immunol. 131:948-953.
15. James, S. L., and J. Glaven. 1989. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. J. Immunol. 143:4208-4212.
16. James, S. L., J. Glaven, S. Goldenberg, M. S. Meltzer, and E. Pearce. 1990. Tumour necrosis factor (TNF) as a mediator of macrophage helminthotoxic activity. Parasite Immunol. 12:1-9.
17. James, S. L., and D. L. Boros. 1994. Immune effector role of macrophages in experimental schistosomiasis mansoni. Immunol. Ser. 60:461-473.
18. James, S. L. 1995. Role of nitric oxide in parasitic infections. Microbiol. Rev. 59:533-547.
19. Jankovic, D. Personal communication.
20. Kassim, O. O., D. A. Dean, B. L. Mangold, and F. Von Lichtenberg. 1992. Combined microautoradiographic and histopathologic analysis of the fate of challenge Schistosoma mansoni schistosomula in mice immunized with irradiated cercariae. Am. J. Trop. Med. Hyg. 47:231-237.
21. Liew, F. Y. 1995. Nitric oxide in infectious and autoimmune diseases. Ciba Found. Symp. 195:234-44.
22. Liew, F. Y. 1995. Regulation of lymphocyte functions by nitric oxide. Curr. Opin. Immunol. 7:396-399.
23. MacMicking, J., Q. W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323-350.
24. MacMicking, J. D., C. Nathan, G. Hom, N. Chartrain, D. S. Fletcher, M. Trumbauer, K. Stevens, Q. W. Xie, K. Sokol, N. Hutchinson, et al. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641-650.
25. Mangold, B. L., and D. A. Dean. 1986. Passive transfer with serum and IgG antibodies of irradiated cercaria-induced resistance against Schistosoma mansoni in mice. J. Immunol. 136:2644-2648.
26. McInnes, I. B., B. Leung, X.-Q. Wei, C. C. Gemmell, and F. Y. Liew. 1998. Septic arthritis following Staphylococcus aureus infection in mice lacking inducible nitric oxide synthase. J. Immunol. 160:308-317.
27. Mills, C. D. 1991. Molecular basis of "suppressor" macrophages. Arginine metabolism via the nitric oxide synthetase pathway. J. Immunol. 146:2719-2723.
28. Minard, P., D. A. Dean, R. H. Jacobson, W. E. Vannier, and K. D. Murrell. 1978. Immunization of mice with cobalt-60 irradiated Schistosoma mansoni cercariae. Am. J. Trop. Med. Hyg. 27:76-86.
29. Nukaya, I., K. Takagi, T. Kawabe, and Y. Suketa. 1995. Suppression of cytokine production in T helper type 2 cells by nitric oxide in comparison with T helper type 1 cells. Microbiol. Immunol. 39:709-714.
30. Oswald, I. P., T. A. Wynn, A. Sher, and S. L. James. 1992. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. Proc. Natl. Acad. Sci. USA 89:8676-8680.
31. Oswald, I. P., I. Eltoum, T. A. Wynn, B. Schwartz, P. Caspar, D. Paulin, A. Sher, and S. L. James. 1994. Endothelial cells are activated by cytokine treatment to kill an intravascular parasite, Schistosoma mansoni, through the production of nitric oxide. Proc. Natl. Acad. Sci. USA 91:999-1003.
32. Sher, A., R. L. Coffman, S. Hieny, and A. W. Cheever. 1990. Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J. Immunol. 145:3911-3916.
33. Shibuya, K., D. Robinson, F. Zonin, S. B. Hartley, S. E. Macatonia, C. Somoza, C. A. Hunter, K. M. Murphy, and A. O'Garra. 1998. IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice. J. Immunol. 160:1708-1716.
34. Sicher, S. C., M. A. Vazquez, and C. Y. Lu. 1994. Inhibition of macrophage Ia expression by nitric oxide. J. Immunol. 153:1293-1300.
35. Smythies, L. E., P. S. Coulson, and R. A. Wilson. 1992. Monoclonal antibody to IFN-gamma modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae. J. Immunol. 149:3654-3658.
36. Smythies, L. E., P. S. Coulson, and R. A. Wilson. 1993. Immunity to Schistosoma mansoni in mice vaccinated with irradiated cercariae: cytokine interactions in the pulmonary protective response. Ann. Trop. Med. Parasitol. 87:653-657.
37. Taylor-Robinson, A. W. 1997. Counter-regulation of T helper 1 cell proliferation by nitric oxide and interleukin-2. Biochem. Biophys. Res. Commun. 233:14-19.
38. Urban, J. L., H. M. Shepard, J. L. Rothstein, B. J. Sugarman, and H. Schreiber. 1986. Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages. Proc. Natl. Acad. Sci. USA 83:5233-5237.
39. Vignali, D. A., P. Crocker, Q. D. Bickle, S. Cobbold, H. Waldmann, and M. G. Taylor. 1989. A role for CD4+ but not CD8+ T cells in immunity to Schistosoma mansoni induced by 20 krad-irradiated and Ro 11-3128-terminated infections. Immunology 67:466-472.
40. Wei, X.Q., I. G. Charles, A. Smith, J. Ure, G. J. Feng, F. P. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408-411.
41. Wilson, R. A., P. S. Coulson, and B. Dixon. 1986. Migration of the schistosomula of Schistosoma mansoni in mice vaccinated with radiation-attenuated cercariae, and normal mice: an attempt to identify the timing and site of parasite death. Parasitology 92:101-116.
42. Wilson, R. A., P. S. Coulson, C. Betts, M. A. Dowling, and L. E. Smythies. 1996. Impaired immunity and altered pulmonary responses in mice with a disrupted interferon-gamma receptor gene exposed to the irradiated Schistosoma mansoni vaccine. Immunology 87:275-282.
43. Wynn, T. A., I. Eltoum, A. W. Cheever, F. A. Lewis, W. C. Gause, and A. Sher. 1993. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J. Immunol. 151:1430-1440.
44. Wynn, T. A., I. P. Oswald, I. A. Eltoum, P. Caspar, C. J. Lowenstein, F. A. Lewis, S. L. James, and A. Sher. 1994. Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni. J. Immunol. 153:5200-5209.
45. Wynn, T. A., I. Eltoum, I. P. Oswald, A. W. Cheever, and A. Sher. 1994. Endogenous interleukin 12 (1L-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J. Exp. Med. 179:1551-1561.
46. Wynn, T. A., D. Jankovic, S. Hieny, A. W. Cheever, and A. Sher. 1995. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J. Immunol. 154:4701-4709.
47. Wynn, T. A., A. Reynolds, S. James, A. W. Cheever, P. Caspar, S. Hieny, D. Jankovic, M. Strand, and A. Sher. 1996. IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite. J. Immunol. 157:4068-4078.